title: The perils of surrogate endpoints.
authors.affiliation: Cardiology Section, Christiana Care Health System, 4755 Ogletown-Stanton Road, Newark, DE 19317, USA wweintraub@christianacare.org.
authors.forename: William S
authors.initials: WS
authors.lastname: Weintraub
authors.affiliation: Department of Cardiology, University Heart Center, University of Zurich, Zurich, Switzerland.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Lüscher
authors.affiliation: Switzerland and London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: Stuart
authors.initials: S
authors.lastname: Pocock
mesh_terms: D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000628:therapy*; D015984:Causality; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy; D003925:Diabetic Angiopathies / Q000628:therapy; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000628:therapy
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL